Search research articles
Contact Us
Filters
Showing results (231-240 of 377) with videos related to
Page
of 38
Sort By:
Journal of Nephrology
|
May 29, 2020
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up
Lorenza Maria Argolini, Giulia Frontini, Elena Elefante, et al.
Rheumatology (Oxford, England)
|
September 5, 2025
A new characteristıc of systemic lupus erythematosus: subclinical vein involvement-an in-depth biochemical and imaging study
Derya Yildirim, Abdulsamet Erden, Nemat Ibrahimkhanli, et al.
Rheumatology (Oxford, England)
|
February 16, 2021
Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study
Chiara Tani, Dina Zucchi, Isabell Haase, et al.
Annals of the Rheumatic Diseases
|
June 24, 2021
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
Katerina Chavatza, Myrto Kostopoulou, Dionysis Nikolopoulos, et al.
Journal of Autoimmunity
|
July 5, 2016
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study
Gabriella Moroni, Andrea Doria, Elisa Giglio, et al.
Lancet (London, England)
|
February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
Michelle Petri, Ian N Bruce, Thomas Dörner, et al.
Lancet (London, England)
|
February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
Eric F Morand, Edward M Vital, Michelle Petri, et al.
RMD Open
|
September 2, 2020
Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey
Rosaria Talarico, Diana Marinello, Stefano Bombardieri, et al.
Clinical and Experimental Rheumatology
|
October 21, 2014
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'
Mirko Scarsi, Antonella Radice, Francesca Pregnolato, et al.
Scientific Reports
|
November 11, 2025
Argo Delphi consensus statement on red flags and clinical gateways towards rare disease diagnosis
Giuseppe Limongelli, Fabio De Iaco, Marta Mosca, et al.
Page
of 38
Search research articles
Search
Showing results (231-240 of 377) with videos related to
Sort By:
Page
of 38
Journal of Nephrology
|
May 29, 2020
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up
Lorenza Maria Argolini, Giulia Frontini, Elena Elefante, et al.
Rheumatology (Oxford, England)
|
September 5, 2025
A new characteristıc of systemic lupus erythematosus: subclinical vein involvement-an in-depth biochemical and imaging study
Derya Yildirim, Abdulsamet Erden, Nemat Ibrahimkhanli, et al.
Rheumatology (Oxford, England)
|
February 16, 2021
Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study
Chiara Tani, Dina Zucchi, Isabell Haase, et al.
Annals of the Rheumatic Diseases
|
June 24, 2021
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
Katerina Chavatza, Myrto Kostopoulou, Dionysis Nikolopoulos, et al.
Journal of Autoimmunity
|
July 5, 2016
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study
Gabriella Moroni, Andrea Doria, Elisa Giglio, et al.
Lancet (London, England)
|
February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
Michelle Petri, Ian N Bruce, Thomas Dörner, et al.
Lancet (London, England)
|
February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
Eric F Morand, Edward M Vital, Michelle Petri, et al.
RMD Open
|
September 2, 2020
Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey
Rosaria Talarico, Diana Marinello, Stefano Bombardieri, et al.
Clinical and Experimental Rheumatology
|
October 21, 2014
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'
Mirko Scarsi, Antonella Radice, Francesca Pregnolato, et al.
Scientific Reports
|
November 11, 2025
Argo Delphi consensus statement on red flags and clinical gateways towards rare disease diagnosis
Giuseppe Limongelli, Fabio De Iaco, Marta Mosca, et al.
Page
of 38